Effect of resveratrol on proliferation and differentiation of embryonic cardiomyoblasts

Biochemical and Biophysical Research Communications

Volumn 360, Issue 1, 2007, Pages 173-180

  Leong, Chi Weng ^a   Wong, Chi Hang ^b   Lao, Sin Cheng ^a   Leong, Emilia Conceição ^a   Lao, Iok Fong ^a   Law, Patrick Tik Wan ^b   Fung, Kwok Pui ^b   Tsang, Kam Sze ^b   Waye, Mary Miu Yee ^b   Tsui, Stephen Kwok Wing ^b   Wang, Yi Tao ^a   Lee, Simon Ming Yuen ^a,b  

^a University of Macau   (Macao)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiomyoblast; Differentiation; Resveratrol

Indexed keywords

CONTRACTILE PROTEIN; CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; MYOGENIN; MYOSIN LIGHT CHAIN; PROTEIN MLC 2; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLAST CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUSION; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EMBRYO; GENE EXPRESSION; HEART MUSCLE CELL; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

VITACEAE;

EID: 34250805373     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.025     Document Type: Article

References (39)

1. Pineiro Z., Palma M., and Barroso C.G. Determination of trans-resveratrol in grapes by pressurised liquid extraction and fast high-performance liquid chromatography. J. Chromatogr. 1110 (2006) 61-65
2. Siemann E.H., and Creasy L.L. Concentration of phytoalexin resveratrol in wine. Am. J. Enol. Viticult. 43 (1992) 49-52
3. Tokusoglu O., Unal M.K., and Yemis F. Determination of the phytoalexin resveratrol (3,5,4′-trihydroxystilbene) in peanuts and pistachios by high-performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). J. Agric. Food Chem. 53 (2005) 5003-5009
4. Lyons M.M., Yu C., Toma R.B., Cho S.Y., Reiboldt W., Lee J., and van Breemen R.B. Resveratrol in raw and baked blueberries and bilberries. J. Agric. Food Chem. 51 (2003) 5867-5870
5. Siemann E.H., and Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Viticult. 43 (1992) 49-52
6. Howitz K.T., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
7. Viswanathan M., Kim S.K., Berdichevsky A., and Guarente L. A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev. Cell 9 (2005) 605-615
8. Valenzano D.R., et al. Resveratrol prolongs lifespan and retards the onset of age related markers in a short-lived vertebrate. Curr. Biol. 16 (2006) 296-300
9. Mokni M., Limam F., Elkahoui S., Amri M., and Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch. Biochem. Biophys. 457 (2007) 1-6
10. Das S., Fraga C.G., and Das D.K. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic. Res. 40 (2006) 066-1075
11. Hung L.M., Su M.J., and Chen J.K. Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic. Biol. Med. 6 (2004) 774-781
12. Lee B., and Moon S.K. Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J. Nutr. 135 (2005) 2767-2773
13. Huang H.M., Liang Y.C., Cheng T.H., Chen C.H., and Juan S.H. Potential mechanism of blood vessel protection by resveratrol, a component of red wine. Ann. N. Y. Acad. Sci. 1042 (2005) 349-356
14. Manna S.K., Mukhopadhyay A., and Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164 (2000) 6509-6519
15. Cao Z., and Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489 (2004) 39-48
16. Stef G., Csiszar A., Lerea K., Ungvari Z., and Veress G. Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance. J. Cardiovasc. Pharmacol. 48 (2006) 1-5
17. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
18. Matsuura K., Nagai T., Nishigaki N., Oyama T., Nishi J., Wada H., Sano M., Toko H., Akazawa H., Sato T., Nakaya H., Kasanuki H., and Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 279 (2004) 11384-11391
19. Ishida M., Tomita S., Nakatani T., Fukuhara S., Hamamoto M., Nagaya N., Ohtsu Y., Suga M., Yutani C., Yagihara T., Yamada K., and Kitamura S. Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy. J. Heart Lung Transplant 23 (2004) 436-445
20. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98 (2001) 10344-10349
21. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
22. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., and Dzau V.J. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9 (2003) 1195-1201
23. Kimes B.W. Brandt BL: properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98 (1976) 367-381
24. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., and Schultz G. Morphological biochemical and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 69 (1991) 1476-1486
25. Merten K.E., and Jiang Y. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. J. Pharmacol. Exp. Ther. 319 (2006) 934-940
26. Khaw B.A., Torchilin V.P., Vural I., and Narula J. Plug, seal, prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nat. Med. 1 (1995) 1195-1198
27. Wu M.L., Tsai K.L., Wang S.M., Wu J.C., Wang B.S., and Lee Y.T. Mechanism of hydrogen peroxide and hydroxyl free radical-induced intracellular acidification in cultured rat cardiac myoblasts. Circ. Res. 78 (1996) 564-572
28. Pagano M., and Naviglio S. Differentiation of H9c2 cardiomyoblasts: the role of adenylate cyclase system. J. Cell Physiol. 198 (2004) 408-416
29. Hong F., Moon K., Kim S.S., Kim Y.S., Choi Y.K., Bae Y.S., Suh P.G., Ryu S.H., Choi E.J., Ha J., and Kim S.S. Role of phospholipase C-gamma1 in insulin-like growth factor I-induced muscle differentiation of H9c2 cardiac myoblasts. Biochem. Biophys. Res. Commun. 202 (2001) 816-822
30. Ito H., Hiroe M., et al. Insulin like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 87 (1993) 1715-1721
31. Hamano T., and Kobayashi K. Peroxisome prolifertator-activated receptor (PPAR α) agonist, WY-146-43, increased transcription of myosin light chain-2 in cardiomyocytes. J. Toxicol. Sci. 26 (2001) 275
32. Wade R., and Eddy R. cDNA sequence, tissue-specific expression, and chromosomal mapping of the human slow-twitch skeletal muscle isoform of troponin I. Genomics 7 (1990) 346-357
33. Taubman M.B., and Smith C.W.A. The expression of sarcomeric muscle-specific contractile protein genes in BC3H1 cells: BC3H1 cells resemble skeletal myoblasts that are defective for commitment to terminal differentiation. J. Cell Biol. 108 (1989) 1799-1806
34. Karsner H.T., Saphir O., and Todd T.W. The state of the cardiac muscle in hypertrophy and atrophy. Am. J. Pathol. 1 (1925) 351-371
35. Beltrami A.P., and Urbanek K. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344 (2001) 1750-1757
36. Beltrami A.P., and Barlucchi L. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
37. Urbanek K., Torella D., and Sheikh F. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. USA 102 (2005) 8692-8697
38. Burrell J.H., and Boyn A.M. Growth and maturation of cardiac myocytes in fetal sheep in the second half of gestation. Anat. Rec. 274A (2003) 952-961
39. Olson E.R., and Naugle J.E. Inhibition of cardiac fibroblast proliferation and myofirbroblast differentiation by resveratrol. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) 1131-1138